CY1121241T1 - Μεθοδος αναμειξης χωρις διαλυτη για την επικαλυψη φαρμακευτικων συστατικων - Google Patents

Μεθοδος αναμειξης χωρις διαλυτη για την επικαλυψη φαρμακευτικων συστατικων

Info

Publication number
CY1121241T1
CY1121241T1 CY20181100951T CY181100951T CY1121241T1 CY 1121241 T1 CY1121241 T1 CY 1121241T1 CY 20181100951 T CY20181100951 T CY 20181100951T CY 181100951 T CY181100951 T CY 181100951T CY 1121241 T1 CY1121241 T1 CY 1121241T1
Authority
CY
Cyprus
Prior art keywords
solvent
particles
mixing method
pharmaceutical ingredients
coated
Prior art date
Application number
CY20181100951T
Other languages
Greek (el)
English (en)
Inventor
Rajesh N. Dave
Daniel TO
Maxx CAPECE
Original Assignee
New Jersey Institute Of Technology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by New Jersey Institute Of Technology filed Critical New Jersey Institute Of Technology
Publication of CY1121241T1 publication Critical patent/CY1121241T1/el

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005Wall or coating material
    • A61K9/5021Organic macromolecular compounds
    • A61K9/5036Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005Wall or coating material
    • A61K9/5063Compounds of unknown constitution, e.g. material from plants or animals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5089Processes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/02Nutrients, e.g. vitamins, minerals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Botany (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Nutrition Science (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CY20181100951T 2012-10-15 2018-09-13 Μεθοδος αναμειξης χωρις διαλυτη για την επικαλυψη φαρμακευτικων συστατικων CY1121241T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US13/651,977 US9107851B2 (en) 2012-10-15 2012-10-15 Solventless mixing process for coating pharmaceutical ingredients
PCT/US2013/064058 WO2014062444A1 (en) 2012-10-15 2013-10-09 Solventless mixing process for coating pharmaceutical ingredients

Publications (1)

Publication Number Publication Date
CY1121241T1 true CY1121241T1 (el) 2020-05-29

Family

ID=49474713

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20181100951T CY1121241T1 (el) 2012-10-15 2018-09-13 Μεθοδος αναμειξης χωρις διαλυτη για την επικαλυψη φαρμακευτικων συστατικων

Country Status (16)

Country Link
US (1) US9107851B2 (cg-RX-API-DMAC7.html)
EP (1) EP2906205B1 (cg-RX-API-DMAC7.html)
JP (1) JP6159504B2 (cg-RX-API-DMAC7.html)
CN (1) CN104853751B (cg-RX-API-DMAC7.html)
AR (1) AR093013A1 (cg-RX-API-DMAC7.html)
BR (1) BR112015008285B1 (cg-RX-API-DMAC7.html)
CY (1) CY1121241T1 (cg-RX-API-DMAC7.html)
DK (1) DK2906205T3 (cg-RX-API-DMAC7.html)
ES (1) ES2688889T3 (cg-RX-API-DMAC7.html)
HR (1) HRP20181463T1 (cg-RX-API-DMAC7.html)
HU (1) HUE039772T2 (cg-RX-API-DMAC7.html)
PL (1) PL2906205T3 (cg-RX-API-DMAC7.html)
PT (1) PT2906205T (cg-RX-API-DMAC7.html)
RS (1) RS57918B1 (cg-RX-API-DMAC7.html)
SI (1) SI2906205T1 (cg-RX-API-DMAC7.html)
WO (1) WO2014062444A1 (cg-RX-API-DMAC7.html)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016011412A1 (en) 2014-07-17 2016-01-21 Ada Technologies, Inc. Extreme long life, high energy density batteries and method of making and using the same
CN104587472B (zh) * 2014-12-31 2017-12-15 广东国方医药科技有限公司 一种含纳米SiO2的包衣剂及其制备方法
WO2016209460A2 (en) 2015-05-21 2016-12-29 Ada Technologies, Inc. High energy density hybrid pseudocapacitors and method of making and using the same
US12401042B2 (en) 2015-06-01 2025-08-26 Forge Nano Inc. Nano-engineered coatings for anode active materials, cathode active materials, and solid-state electrolytes and methods of making batteries containing nano-engineered coatings
US12027661B2 (en) 2015-06-01 2024-07-02 Forge Nano Inc. Nano-engineered coatings for anode active materials, cathode active materials, and solid-state electrolytes and methods of making batteries containing nano-engineered coatings
US11996564B2 (en) 2015-06-01 2024-05-28 Forge Nano Inc. Nano-engineered coatings for anode active materials, cathode active materials, and solid-state electrolytes and methods of making batteries containing nano-engineered coatings
US10692659B2 (en) 2015-07-31 2020-06-23 Ada Technologies, Inc. High energy and power electrochemical device and method of making and using same
JP7069538B2 (ja) * 2016-12-05 2022-05-18 マルボシ酢株式会社 食酢含有飲料組成物
US11024846B2 (en) 2017-03-23 2021-06-01 Ada Technologies, Inc. High energy/power density, long cycle life, safe lithium-ion battery capable of long-term deep discharge/storage near zero volt and method of making and using the same
JPWO2019009335A1 (ja) * 2017-07-04 2020-07-02 村上 正裕 微粒子の製造方法及び微粒子
AU2020223894B2 (en) * 2019-02-22 2025-09-18 Catalent U.K. Swindon Zydis Limited Minimizing agglomeration, aeration, and preserving the coating of pharmaceutical compositions comprising Ibuprofen
HUE064287T2 (hu) * 2019-02-22 2024-02-28 Catalent Uk Swindon Zydis Ltd Hatóanyagrészecske-bevonóanyag agglomerálódásának minimalizálása tárolás során, gyógyszerészeti termékek szétesési idejének stabilizálására
EP3927313B1 (en) * 2019-02-22 2025-12-24 Catalent U.K. Swindon Zydis Limited Preserving functionally-coated api particles produced by solventless mixing processes in aqueous suspension
ES2961850T3 (es) 2019-02-22 2024-03-14 Catalent Uk Swindon Zydis Ltd Minimización de la aireación de suspensiones durante la mezcla en línea
US20210009767A1 (en) * 2019-07-11 2021-01-14 International Flavors & Fragrances Inc. Solventless particle coating via acoustic mixing
US12285731B2 (en) 2019-09-12 2025-04-29 United States Of America, As Represented By The Secretary Of The Army Acoustic mixing system for creating propellant mixture
MX2023001004A (es) 2020-07-31 2023-03-01 Catalent Uk Swindon Zydis Ltd Composiciones farmaceuticas que comprenden un ingrediente farmaceutico activo (api) recubierto.

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5628945A (en) 1992-08-03 1997-05-13 Riman; Richard E. Multicomponent powder mixing process and compositions produced thereby
WO1994015374A1 (fr) * 1992-12-25 1994-07-07 Tdk Corporation Element secondaire au lithium
US5769917A (en) * 1996-12-09 1998-06-23 Belko; William C. Process for producing low shrink ceramic bodies
US6740341B1 (en) 1998-11-25 2004-05-25 Cima Labs Inc. Taste masking rapid release coating system
DE10062176A1 (de) * 2000-12-14 2002-07-04 Wacker Polymer Systems Gmbh Polyvinylacetal-gepfropfte Polymerisate
US8163114B2 (en) 2004-04-07 2012-04-24 New Jersey Institute Of Technology Netshape manufacturing processes and compositions
DE102004059792A1 (de) * 2004-12-10 2006-06-14 Röhm GmbH & Co. KG Multipartikuläre Arzneiform, enthaltend mucoadhaesiv formulierte Nukleinsäure-Wirkstoffe, sowie ein Verfahren zur Herstellung der Arzneiform
US20060210694A1 (en) * 2005-03-18 2006-09-21 Chappell Rulon A Anti-caking agents and methods
WO2007014464A1 (en) 2005-08-03 2007-02-08 The University Of Western Ontario Direct coating solid dosage forms using powdered materials
PT2570120T (pt) 2010-06-08 2018-01-09 Nippon Soda Co Partículas revestidas e processo de produção de partículas revestidas
GB201205632D0 (en) 2012-03-30 2012-05-16 Vectura Ltd Method and apparatus
US8993041B2 (en) * 2012-10-15 2015-03-31 New Jersey Institute Of Technology Taste masked active pharmaceutical powder compositions and processes for making them

Also Published As

Publication number Publication date
ES2688889T3 (es) 2018-11-07
PT2906205T (pt) 2018-11-07
JP6159504B2 (ja) 2017-07-05
CN104853751A (zh) 2015-08-19
US20140106059A1 (en) 2014-04-17
CN104853751B (zh) 2018-06-22
HUE039772T2 (hu) 2019-02-28
HRP20181463T1 (hr) 2018-12-14
PL2906205T3 (pl) 2019-03-29
BR112015008285A2 (pt) 2017-07-04
EP2906205B1 (en) 2018-06-13
SI2906205T1 (sl) 2018-12-31
US9107851B2 (en) 2015-08-18
AR093013A1 (es) 2015-05-13
JP2015533162A (ja) 2015-11-19
BR112015008285B1 (pt) 2022-11-16
EP2906205A1 (en) 2015-08-19
RS57918B1 (sr) 2019-01-31
DK2906205T3 (en) 2018-09-24
WO2014062444A1 (en) 2014-04-24

Similar Documents

Publication Publication Date Title
CY1121241T1 (el) Μεθοδος αναμειξης χωρις διαλυτη για την επικαλυψη φαρμακευτικων συστατικων
Mahmoudi et al. Interaction of stable colloidal nanoparticles with cellular membranes
CY1125419T1 (el) Μεθοδος παρασκευης στερεων νανοσωματιδιων με ανοργανη επικαλυψη και χρηση αυτων
IL263274A (en) Covalently adapted surfaces, kits and methods for their production and uses
CY1124331T1 (el) Αυξημενη βιοδιαθεσιμοτητα δραστικης ουσιας σε θεραπεια ναλτρεξονης
AU2018348359A8 (en) Extended release pharmaceutical formulation and methods of treatment
WO2015160975A3 (en) Combination of a pi3k inhibitor with a bcl-2 inhibitor for use in the treatment of cancer
HK1216083A1 (zh) 经动脉的药物递送
EP3592746A4 (en) TYK2 INHIBITORS, THEIR USES AND THEIR PRODUCTION PROCESSES
CY1124041T1 (el) Συνθεσεις που περιλαμβανουν κυκλοσπορινη
EP3277806A4 (en) Methods of forming nanostructures using self-assembled nucleic acids, and nanostructures thereof
CY1123022T1 (el) Σταθερες φαρμακευτικες συνθεσεις που περιεχουν σιταγλιπτινη υπο τη μορφη δισκιων αμεσης απελευθερωσης
WO2014153495A9 (en) Novel stat3 inhibitors
EP3558384A4 (en) BIOCOMPATIBLE AND HYDROPHILIC POLYMER CONJUGATE INTENDED FOR THE TARGETED ADMINISTRATION OF AN AGENT
GB2528421A (en) Methods and processes for application of drug delivery polymeric coatings
PT3380526T (pt) Processo ecológico para a preparação de nanocelulose e derivados desta
EP3595638A4 (en) PHARMACEUTICAL COMPOSITIONS WITH HIGH DRUG LOADS BASED ON MEDIUM-CHAIN TRIGLYCERIDES AND RELATED METHODS
PH12014502834A1 (en) Pharmaceutical form for extended release of active substances
WO2015095659A3 (en) Indirubin solid dispersion composition
MX394131B (es) Partículas revestidas y sus usos.
MX390441B (es) Formulaciones liquidas de fosfaplatino.
WO2017120098A8 (en) Stimuli-responsive polymeric nanoparticles, methods of making stimuli-responsive polymeric nanoparticles, and methods of using stimuli-responsive polymeric nanoparticles
BR112017012400A8 (pt) Complexo fármaco-resina, partícula de liberação estendida, formulação farmacêutica, método para formar um complexo de fármaco-resina revestido e processo para a preparação de um complexo fármaco-resina
SA118400097B1 (ar) تخليق جسيمات حمض الإيفلايونيك متناهي الصغر
EA201201329A1 (ru) Новая композиция для лечения эссенциальной тромбоцитемии